EpiPen outrage may fuel cheap generic in 2017
August 26, 2016 at 12:23 PM EDT
EpiPen price hike outrage could speed FDA approval of an alternative by Teva as early as 2017.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.